Melody Sauerborn

550 total citations
10 papers, 441 citations indexed

About

Melody Sauerborn is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Melody Sauerborn has authored 10 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Melody Sauerborn's work include Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (4 papers). Melody Sauerborn is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (4 papers). Melody Sauerborn collaborates with scholars based in Netherlands, Italy and Singapore. Melody Sauerborn's co-authors include Huub Schellekens, Vera Brinks, Wim Jiskoot, Miranda M. C. van Beers, Francesca Gilli, Grzegorz Kijanka, Suzanne Hermeling, Louis Boon, Diyar Delawi and Jaap T. van Dissel and has published in prestigious journals such as Trends in Pharmacological Sciences, Current Opinion in Biotechnology and Pharmaceutical Research.

In The Last Decade

Melody Sauerborn

10 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melody Sauerborn Netherlands 9 307 265 184 54 40 10 441
Grzegorz Kijanka Netherlands 10 221 0.7× 171 0.6× 126 0.7× 43 0.8× 31 0.8× 11 338
Ramesh S. Kashi United States 8 290 0.9× 229 0.9× 104 0.6× 25 0.5× 103 2.6× 9 495
Armin Sepp United Kingdom 13 301 1.0× 183 0.7× 89 0.5× 21 0.4× 63 1.6× 36 484
Bruce Andrien United States 9 246 0.8× 189 0.7× 203 1.1× 20 0.4× 23 0.6× 12 479
Yuka Mimura‐Kimura Japan 8 360 1.2× 179 0.7× 149 0.8× 33 0.6× 46 1.1× 15 496
Sofia Castelli United States 7 161 0.5× 103 0.4× 107 0.6× 19 0.4× 138 3.5× 11 355
Lindsay E. King United States 11 308 1.0× 307 1.2× 274 1.5× 8 0.1× 127 3.2× 15 542
Robin Marsden United States 7 168 0.5× 158 0.6× 143 0.8× 10 0.2× 142 3.5× 8 436
Chi-Kin Chow United States 5 130 0.4× 134 0.5× 174 0.9× 13 0.2× 34 0.8× 10 325
Jürgen Schanzer Switzerland 7 468 1.5× 479 1.8× 141 0.8× 13 0.2× 162 4.0× 8 716

Countries citing papers authored by Melody Sauerborn

Since Specialization
Citations

This map shows the geographic impact of Melody Sauerborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melody Sauerborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melody Sauerborn more than expected).

Fields of papers citing papers by Melody Sauerborn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melody Sauerborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melody Sauerborn. The network helps show where Melody Sauerborn may publish in the future.

Co-authorship network of co-authors of Melody Sauerborn

This figure shows the co-authorship network connecting the top 25 collaborators of Melody Sauerborn. A scholar is included among the top collaborators of Melody Sauerborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melody Sauerborn. Melody Sauerborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kijanka, Grzegorz, Melody Sauerborn, Louis Boon, Huub Schellekens, & Vera Brinks. (2014). Development of ADA Against Recombinant Human Interferon Beta in Immune Tolerant Mice Requires Rapid Recruitment of CD4+ T Cells, Induces Formation of Germinal Centers but Lacks Susceptibility for (Most) Adjuvants. Journal of Pharmaceutical Sciences. 104(2). 396–406. 7 indexed citations
2.
Sauerborn, Melody, et al.. (2014). Practical Considerations for the Pharmacokinetic and Immunogenic Assessment of Antibody–Drug Conjugates. BioDrugs. 28(4). 383–391. 16 indexed citations
3.
Torosantucci, Riccardo, Vera Brinks, Grzegorz Kijanka, et al.. (2014). Development of a Transgenic Mouse Model to Study the Immunogenicity of Recombinant Human Insulin. Journal of Pharmaceutical Sciences. 103(5). 1367–1374. 15 indexed citations
4.
Sauerborn, Melody, Miranda M. C. van Beers, Wim Jiskoot, et al.. (2012). Antibody Response Against Betaferon® in Immune Tolerant Mice: Involvement of Marginal Zone B-cells and CD4+ T-cells and Apparent Lack of Immunological Memory. Journal of Clinical Immunology. 33(1). 255–263. 11 indexed citations
5.
Sauerborn, Melody, Esther van de Vosse, Diyar Delawi, et al.. (2011). Natural Antibodies Against Bone Morphogenic Proteins and Interferons in Healthy Donors and in Patients with Infections Linked to Type-1 Cytokine Responses. Journal of Interferon & Cytokine Research. 31(9). 661–669. 10 indexed citations
6.
Beers, Miranda M. C. van, Melody Sauerborn, Francesca Gilli, et al.. (2011). Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice. Pharmaceutical Research. 28(10). 2393–2402. 100 indexed citations
7.
Beers, Miranda M. C. van, Melody Sauerborn, Francesca Gilli, et al.. (2010). Aggregated Recombinant Human Interferon Beta Induces Antibodies but No Memory in Immune-Tolerant Transgenic Mice. Pharmaceutical Research. 27(9). 1812–1824. 81 indexed citations
8.
Sauerborn, Melody, Vera Brinks, Wim Jiskoot, & Huub Schellekens. (2009). Immunological mechanism underlying the immune response to recombinant human protein therapeutics. Trends in Pharmacological Sciences. 31(2). 53–59. 157 indexed citations
9.
Sauerborn, Melody & Huub Schellekens. (2009). B-1 cells and naturally occurring antibodies: influencing the immunogenicity of recombinant human therapeutic proteins?. Current Opinion in Biotechnology. 20(6). 715–721. 14 indexed citations
10.
Beers, Miranda M. C. van, Melody Sauerborn, Francesca Gilli, et al.. (2009). Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta. Journal of Immunological Methods. 352(1-2). 32–37. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grzegorz Kijanka Breakdown of academic impact, for papers by Ramesh S. Kashi Breakdown of academic impact, for papers by Armin Sepp Breakdown of academic impact, for papers by Bruce Andrien Breakdown of academic impact, for papers by Yuka Mimura‐Kimura Breakdown of academic impact, for papers by Sofia Castelli Breakdown of academic impact, for papers by Lindsay E. King Breakdown of academic impact, for papers by Robin Marsden Breakdown of academic impact, for papers by Chi-Kin Chow Breakdown of academic impact, for papers by Jürgen Schanzer
Rankless by CCL
2026